{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T08:54:31Z","timestamp":1770281671594,"version":"3.49.0"},"reference-count":49,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1016\/j.ygyno.2011.07.024","type":"journal-article","created":{"date-parts":[[2011,8,14]],"date-time":"2011-08-14T16:16:50Z","timestamp":1313338610000},"page":"278-283","source":"Crossref","is-referenced-by-count":40,"title":["Comparison of different commercial methods for HPV detection in follow-up cytology after ASCUS\/LSIL, prediction of CIN2\u20133 in follow up biopsies and spontaneous regression of CIN2\u20133"],"prefix":"10.1016","volume":"123","author":[{"given":"Irene T.","family":"Ovestad","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Undis","family":"Vennestr\u00f8m","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liv","family":"Andersen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Einar","family":"Gudlaugsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ane Cecilie","family":"Munk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anais","family":"Malpica","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weiwei","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feja","family":"Voorhorst","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emiel A.M.","family":"Janssen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan P.A.","family":"Baak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2011.07.024_bb0005","article-title":"Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008","author":"Ferlay","year":"2008","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ygyno.2011.07.024_bb0010","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1093\/jnci\/93.4.293","article-title":"Comparison of three management strategies for patients with atypical squamous cells of undetermined significance: baseline results from a randomized trial","volume":"93","author":"Solomon","year":"2001","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ygyno.2011.07.024_bb0015","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1002\/ijc.21955","article-title":"Overview of the European and North American studies on HPV testing in primary cervical cancer screening","volume":"119","author":"Cuzick","year":"2006","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ygyno.2011.07.024_bb0020","doi-asserted-by":"crossref","first-page":"c1804","DOI":"10.1136\/bmj.c1804","article-title":"Rate of cervical cancer, severe intraepithelial neoplasia, and adenocarcinoma in situ in primary HPV DNA screening with cytology triage: randomised study within organised screening programme","volume":"340","author":"Anttila","year":"2010","journal-title":"BMJ"},{"key":"10.1016\/j.ygyno.2011.07.024_bb0025","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1093\/jnci\/djn444","article-title":"Efficacy of HPV DNA testing with cytology triage and\/or repeat HPV DNA testing in primary cervical cancer screening","volume":"101","author":"Naucler","year":"2009","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ygyno.2011.07.024_bb0030","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1001\/jama.285.11.1500","article-title":"Interobserver reproducibility of cervical cytologic and histologic interpretations: realistic estimates from the ASCUS-LSIL Triage Study","volume":"285","author":"Stoler","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.ygyno.2011.07.024_bb0035","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1002\/ijc.24891","article-title":"Comparison of HPV and cytology triage algorithms for women with borderline or mild dyskaryosis in population-based cervical screening (VUSA-screen study)","volume":"126","author":"Rijkaart","year":"2009","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ygyno.2011.07.024_bb0040","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1097\/01.olq.0000251241.03088.a0","article-title":"The natural history of human papillomavirus infection and cervical intraepithelial neoplasia among young women in the Guanacaste cohort shortly after initiation of sexual life","volume":"34","author":"Rodriguez","year":"2007","journal-title":"Sex Transm Dis"},{"key":"10.1016\/j.ygyno.2011.07.024_bb0045","doi-asserted-by":"crossref","first-page":"a1754","DOI":"10.1136\/bmj.a1754","article-title":"Long term predictive values of cytology and human papillomavirus testing in cervical cancer screening: joint European cohort study","volume":"337","author":"Dillner","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.ygyno.2011.07.024_bb0050","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1097\/AOG.0b013e318168460b","article-title":"An analysis of high-risk human papillomavirus DNA-negative cervical precancers in the ASCUS-LSIL Triage Study (ALTS)","volume":"111","author":"Castle","year":"2008","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ygyno.2011.07.024_bb0055","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F","article-title":"Human papillomavirus is a necessary cause of invasive cervical cancer worldwide","volume":"189","author":"Walboomers","year":"1999","journal-title":"J Pathol"},{"key":"10.1016\/j.ygyno.2011.07.024_bb0060","doi-asserted-by":"crossref","first-page":"S124","DOI":"10.1016\/0090-8258(81)90067-6","article-title":"Papillomavirus infections and human genital cancer","volume":"12","author":"zur Hausen","year":"1981","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2011.07.024_bb0065","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1002\/ijc.24774","article-title":"How to evaluate emerging technologies in cervical cancer screening?","volume":"125","author":"Arbyn","year":"2009","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ygyno.2011.07.024_bb0070","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1002\/path.1233","article-title":"The framework of pathology: good laboratory practice by quantitative and molecular methods","volume":"198","author":"Baak","year":"2002","journal-title":"J Pathol"},{"key":"10.1016\/j.ygyno.2011.07.024_bb0075","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.ygyno.2005.02.026","article-title":"DNA- versus RNA-based methods for human papillomavirus detection in cervical neoplasia","volume":"97","author":"Lie","year":"2005","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2011.07.024_bb0080","doi-asserted-by":"crossref","first-page":"3033","DOI":"10.1158\/1055-9965.EPI-08-0508","article-title":"Comparison of predictors for high-grade cervical intraepithelial neoplasia in women with abnormal smears","volume":"17","author":"Szarewski","year":"2008","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.ygyno.2011.07.024_bb0085","doi-asserted-by":"crossref","first-page":"3344","DOI":"10.1128\/JCM.00725-09","article-title":"Evaluation of a prototype real-time PCR assay for carcinogenic human papillomavirus (HPV) detection and simultaneous HPV genotype 16 (HPV16) and HPV18 genotyping","volume":"47","author":"Castle","year":"2009","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ygyno.2011.07.024_bb0090","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.1128\/JCM.01863-08","article-title":"Performance of human papillomavirus DNA and mRNA testing strategies for women with and without cervical neoplasia","volume":"47","author":"Trope","year":"2009","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ygyno.2011.07.024_bb0095","article-title":"Evaluation of oncogenic human papillomavirus RNA and DNA tests with liquid-based cytology in primary cervical cancer screening: the FASE study","author":"Monsonego","year":"2010","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ygyno.2011.07.024_bb0100","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.ygyno.2010.06.011","article-title":"Performance of p16INK4a-cytology, HPV mRNA, and HPV DNA testing to identify high grade cervical dysplasia in women with abnormal screening results","volume":"119","author":"Reuschenbach","year":"2010","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2011.07.024_bb0105","article-title":"APTIMA HPV E6\/E7 mRNA test is as sensitive as Hybrid Capture 2 assay but more specific at detecting cervical precancer and cancer","author":"Ratnam","year":"2010","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ygyno.2011.07.024_bb0110","doi-asserted-by":"crossref","first-page":"2779","DOI":"10.1128\/JCM.00382-10","article-title":"Clinical performance of the PreTect HPV-Proofer E6\/E7 mRNA assay in comparison with that of the Hybrid Capture 2 test for identification of women at risk of cervical cancer","volume":"48","author":"Ratnam","year":"2010","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ygyno.2011.07.024_bb0115","doi-asserted-by":"crossref","first-page":"3915","DOI":"10.1128\/JCM.01305-06","article-title":"Pilot study of a commercialized human papillomavirus (HPV) genotyping assay: comparison of HPV risk group to cytology and histology","volume":"44","author":"Castle","year":"2006","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ygyno.2011.07.024_bb0120","article-title":"Performance of the APTIMA high-risk HPV mRNA assay in a referral population in comparison with Hybrid Capture 2 and cytology","author":"Clad","year":"2010","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ygyno.2011.07.024_bb0125","article-title":"Comparative evaluation of AMPLICOR HPV PCR and Linear Array assays on SurePath liquid-based Pap samples for the detection of high-risk HPV genotypes","author":"Chernesky","year":"2010","journal-title":"J Clin Virol"},{"key":"10.1016\/j.ygyno.2011.07.024_bb0130","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1158\/1055-9965.EPI-08-1180","article-title":"A study of Amplicor human papillomavirus DNA detection in the atypical squamous cells of undetermined significance-low-grade squamous intraepithelial lesion triage study","volume":"18","author":"Wentzensen","year":"2009","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.ygyno.2011.07.024_bb0135","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1038\/modpathol.2010.109","article-title":"Local immune response in the microenvironment of CIN2\u20133 with and without spontaneous regression","volume":"23","author":"Ovestad","year":"2010","journal-title":"Mod Pathol"},{"key":"10.1016\/j.ygyno.2011.07.024_bb0140","first-page":"733","article-title":"The effect of different DNA isolation methods on the outcome of high-risk HPV testing","volume":"50","author":"Oevestad","year":"2007","journal-title":"Indian J Pathol Microbiol"},{"key":"10.1016\/j.ygyno.2011.07.024_bb0145","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1038\/sj.bjc.6601691","article-title":"Human papillomavirus oncogenic expression in the dysplastic portio; an investigation of biopsies from 190 cervical cones","volume":"90","author":"Kraus","year":"2004","journal-title":"BJC"},{"key":"10.1016\/j.ygyno.2011.07.024_bb0150","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.1158\/1078-0432.CCR-06-2881","article-title":"A cross-sectional study of a prototype carcinogenic human papillomavirus E6\/E7 messenger RNA assay for detection of cervical precancer and cancer","volume":"13","author":"Castle","year":"2007","journal-title":"Clin Cancer Res"},{"issue":"Suppl. 1","key":"10.1016\/j.ygyno.2011.07.024_bb0155","doi-asserted-by":"crossref","first-page":"S55","DOI":"10.1016\/S1386-6532(09)70009-5","article-title":"Clinical performance of the APTIMA HPV Assay for the detection of high-risk HPV and high-grade cervical lesions","volume":"45","author":"Dockter","year":"2009","journal-title":"J Clin Virol"},{"key":"10.1016\/j.ygyno.2011.07.024_bb0160","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1136\/jcp.2010.083626","article-title":"The impact of epithelial biomarkers, local immune response and human papillomavirus genotype in the regression of cervical intraepithelial neoplasia grades 2\u20133","volume":"64","author":"Ovestad","year":"2011","journal-title":"J Clin Pathol"},{"issue":"Suppl. 1","key":"10.1016\/j.ygyno.2011.07.024_bb0165","doi-asserted-by":"crossref","first-page":"S39","DOI":"10.1016\/S1386-6532(09)70007-1","article-title":"Analytical characterization of the APTIMA HPV Assay","volume":"45","author":"Dockter","year":"2009","journal-title":"J Clin Virol"},{"key":"10.1016\/j.ygyno.2011.07.024_bb0170","series-title":"PreTect HPV-Proofer package insert","author":"NorChip","year":"2008"},{"key":"10.1016\/j.ygyno.2011.07.024_bb0175","article-title":"HPV mRNA tests for the detection of cervical intraepithelial neoplasia: a systematic review","author":"Burger","year":"2010","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2011.07.024_bb0180","doi-asserted-by":"crossref","first-page":"8578","DOI":"10.1158\/0008-5472.CAN-10-1188","article-title":"Hierarchical clustering of human papilloma virus genotype patterns in the ASCUS-LSIL triage study","volume":"70","author":"Wentzensen","year":"2010","journal-title":"Cancer Res"},{"key":"10.1016\/j.ygyno.2011.07.024_bb0185","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1309\/AJCPZ5JY6FCVNMOT","article-title":"High-risk human papillomavirus testing in women With ASC-US Cytology: results from the ATHENA HPV Study","volume":"135","author":"Stoler","year":"2011","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.ygyno.2011.07.024_bb0190","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1093\/jnci\/dji186","article-title":"Human papillomavirus type 16 infections and 2-year absolute risk of cervical precancer in women with equivocal or mild cytologic abnormalities","volume":"97","author":"Castle","year":"2005","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ygyno.2011.07.024_bb0195","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1111\/j.1582-4934.2008.00631.x","article-title":"Triage of women with equivocal or low-grade cervical cytology results: a meta-analysis of the HPV test positivity rate","volume":"13","author":"Arbyn","year":"2009","journal-title":"JCMM"},{"issue":"3 Suppl. 1","key":"10.1016\/j.ygyno.2011.07.024_bb0200","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1016\/j.ygyno.2005.07.033","article-title":"Clinical utility of HPV-DNA detection: triage of minor cervical lesions, follow-up of women treated for high-grade CIN: an update of pooled evidence","volume":"99","author":"Arbyn","year":"2005","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2011.07.024_bb0205","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1016\/S0140-6736(03)14955-0","article-title":"Management of women who test positive for high-risk types of human papillomavirus: the HART study","volume":"362","author":"Cuzick","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.ygyno.2011.07.024_bb0210","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/S1470-2045(11)70145-0","article-title":"Cervical cancer risk for women undergoing concurrent testing for human papillomavirus and cervical cytology: a population-based study in routine clinical practice","volume":"12","author":"Katki","year":"2011","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ygyno.2011.07.024_bb0215","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1097\/01.pas.0000167363.13771.47","article-title":"Combined p53 and retinoblastoma protein detection identifies persistent and regressive cervical high-grade squamous intraepithelial lesions","volume":"29","author":"Baak","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ygyno.2011.07.024_bb0220","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1111\/j.1600-0463.2007.00769.x","article-title":"Cervical intraepithelial neoplasia grade 3 lesions can regress","volume":"115","author":"Munk","year":"2007","journal-title":"APMIS"},{"issue":"Suppl. 11","key":"10.1016\/j.ygyno.2011.07.024_bb0225","doi-asserted-by":"crossref","first-page":"L88","DOI":"10.1016\/j.vaccine.2008.05.026","article-title":"Integration of human papillomavirus vaccination and cervical cancer screening in Latin America and the Caribbean","volume":"26","author":"Franco","year":"2008","journal-title":"Vaccine"},{"issue":"Suppl. 11","key":"10.1016\/j.ygyno.2011.07.024_bb0230","doi-asserted-by":"crossref","first-page":"L49","DOI":"10.1016\/j.vaccine.2008.05.025","article-title":"New approaches to cervical cancer screening in Latin America and the Caribbean","volume":"26","author":"Herrero","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.ygyno.2011.07.024_bb0235","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1093\/jnci\/dji162","article-title":"Cost-effectiveness of human papillomavirus DNA testing in the United Kingdom, The Netherlands, France, and Italy","volume":"97","author":"Kim","year":"2005","journal-title":"J Natl Cancer Inst"},{"issue":"Suppl. 11","key":"10.1016\/j.ygyno.2011.07.024_bb0240","doi-asserted-by":"crossref","first-page":"L37","DOI":"10.1016\/j.vaccine.2008.06.013","article-title":"Cervical cancer screening programs in Latin America and the Caribbean","volume":"26","author":"Murillo","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.ygyno.2011.07.024_bb0245","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1093\/jnci\/djn019","article-title":"Cost-effectiveness of cervical cancer screening with human papillomavirus DNA testing and HPV-16,18 vaccination","volume":"100","author":"Goldhaber-Fiebert","year":"2008","journal-title":"J Natl Cancer Inst"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825811005749?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825811005749?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,9]],"date-time":"2024-04-09T22:50:12Z","timestamp":1712703012000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825811005749"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11]]},"references-count":49,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,11]]}},"alternative-id":["S0090825811005749"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2011.07.024","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2011,11]]}}}